Salas Eduardo Rene has filed 5 insider transactions across 1 company since December 2024.
Most recent transaction: a grant/award of 10690 shares of ADMA BIOLOGICS, INC. ($ADMA) on February 09, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 9, 2026 | ADMA BIOLOGICS, INC. | $ADMA | Salas Eduardo Rene | Not found | A | Common Stock | 10690 | $0.00 | 21,579.0000 | 243,342,466 | 98.17% | 0.00% |
| Feb. 9, 2026 | ADMA BIOLOGICS, INC. | $ADMA | Salas Eduardo Rene | Not found | A | Stock Option (Right to Buy) | 17730 | $0.00 | 17,730.0000 | 243,342,466 | 9999.99% | 0.01% |
| Feb. 19, 2025 | ADMA BIOLOGICS, INC. | $ADMA | Salas Eduardo Rene | Not found | A | Common Stock | 10889 | $0.00 | 10,889.0000 | 243,342,466 | 9999.99% | 0.00% |
| Feb. 19, 2025 | ADMA BIOLOGICS, INC. | $ADMA | Salas Eduardo Rene | Not found | A | Stock Option (right to buy) | 16279 | $0.00 | 16,279.0000 | 243,342,466 | 9999.99% | 0.01% |
| Dec. 30, 2024 | ADMA BIOLOGICS, INC. | $ADMA | Salas Eduardo Rene | Not found | A | Stock Option (right to buy) | 20011 | $0.00 | 20,011.0000 | 223,977,315 | 9999.99% | 0.01% |